Certification

Breakthrough Device Designation – U.S Food and Drug Administration (Feb. 2025)

Certificate of GMP – Gyeongin regional Food and Drug Administration (Nov. 2024)

NET(New Excellent Technology) – Ministry of Trade Industry and Resources (May 2024)

: Design and Manufacturing Technology for a 3D-Steerable, Non-Thermal Focused Ultrasound Transducer

Awards

IR52 Jang Yeong-sil Award : Technology Innovation Award - Ministry of Science and ICT (Nov. 2024)

Minister's Commendation from the Ministry of Trade, Industry and Energy (MOTIE) (Nov. 2024)

Ministerial Commendation (Award) from the Ministry of Science and ICT (MSIT) (Apr. 2024)

Publication

Mar. 2026 [Ultrasonics]

Comparison of mechanical and thermal effects of focused ultrasound on drug delivery efficiency and toxicity for pancreatic cancer treatment

Mar. 2024[European Radiology]

Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model

Sep. 2023 [Scientific reports]

"Drug delivery by sonosensitive liposome and microbubble with acoustic‑lens attached ultrasound an in vivo feasibility study in a murine melanoma model"

Aug. 2022 [Biomaterials Advances]

"Enhanced delivery to brain using sonosensitive liposome and microbubble with focused ultrasound"

Jul. 2022 [Pharmaceutics]

"Effects of Lipid Shape and Interactions on the Conformation, Dynamics, and Curvature of Ultrasound-Responsive Liposomes"

Jun. 2022 [Pharmaceutics]

"Ultrasound-Responsive Liposomes for Targeted Drug Delivery Combined with Focused Ultrasound"

Sep. 2021 [Pharmaceuticals]

"PMP(Porphyrin-Micelle-PSMA) nanoparticles for photoacoustic and ultrasound signal amplification in Mouse Prostate Cancer Xenografts"

May 2021 [Ultrasonography]

"Early response evaluation of doxorubicin-nanoparticle-microbubble therapy in orthotopic hepatocellular carcinoma rat model using contrast-enhanced ultrasound and intravoxel incohernet motion-diffusion MRI"

Dec. 2021[Pharmaceutics]

PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models

Sep. 2020 [Theranostics]

Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model

Sep. 2020 [PHARMACEUTICALS]

Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts

Jul. 2020 [Ultrasound in medicine and biology]

Synergistic Effects of Pulsed Focused Ultrasound and a Doxorubicin-loaded Microparticle-Microbubble Complex in a Pancreatic Cancer Xenograft Mouse Model

Feb. 2020 [MATERIALS]

Antitumor Efficacy of Focused Ultrasound-MFL Nanoparticles Combination Therapy in Mouse Breast Cancer Xenografts

Nov. 2019 [BULLETIN OF THE KOREAN CHEMICAL SOCIETY]

In vitro Evaluation of Carbon‐Based Nanospheres as Drug Delivery Vesicles in Breast Cancer Cell

Mar. 2020 [International Society for Magnetic Resonance in Medicine]

An Ultrasound-Responsive Dual-Modal US/T1-MRI Contrast Agent for Potential Diagnosis of Prostate Cancer

May 2019 [INTERNATIONAL JOURNAL OF NANOMEDICINE]

Ultrasound-sensitizing nanoparticle complex for overcoming the blood-brain barrier: an effective drug delivery system

Apr. 2019 [cancers]

Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors

Feb. 2019 [The Korea Society of Medical and Biological Engineering]

Effects of Anticancer Drug Delivery based on Microbubble and Microbubble-Nanoparticle Complex using Low-Intensity Focused Ultrasound in Breast Cancer Animal Model

Nov. 2019 [BULLETIN OF THE KOREAN CHEMICAL SOCIETY]

In vitro Evaluation of Carbon‐Based Nanospheres as Drug Delivery Vesicles in Breast Cancer Cell